$VRNS
VARONIS SYSTEMS INC Stock $vrns

$vrns Overview Financials Valuation SEC Filings Company Website

2018 Q3 Form 10-Q Financial Statement

#000162828018009870 Filed on July 31, 2018

Income Statement

Concept	2018 Q3	2018 Q2	2017 Q2
Revenue	$67.05M	$62.19M	$49.43M
YoY Change	25.65%	25.81%	27.92%
Cost Of Revenue	$7.052M	$6.440M	$4.881M
YoY Change	30.04%	31.94%	31.17%
Gross Profit	$60.00M	$55.75M	$44.55M
YoY Change	25.15%	25.14%	27.58%
Gross Profit Margin	89.48%	89.64%	90.13%
Selling, General & Admin	$49.57M	$49.34M	$39.16M
YoY Change	26.55%	25.99%	23.92%
% of Gross Profit	82.61%	88.5%	87.9%
Research & Development	$17.27M	$17.72M	$11.50M
YoY Change	45.06%	54.09%	29.12%
% of Gross Profit	28.78%	31.78%	25.81%
Depreciation & Amortization	$850.0K	$830.0K	$660.0K
YoY Change	23.19%	25.76%	15.79%
% of Gross Profit	1.42%	1.49%	1.48%
Operating Expenses	$66.83M	$67.06M	$50.66M
YoY Change	30.87%	32.37%	25.06%
Operating Profit	-$6.833M	-$11.31M	-$6.107M
YoY Change	118.52%	85.12%	9.35%
Interest Expense	$100.0K	-$810.0K	$950.0K
YoY Change	-83.87%	-185.26%	-255.74%
% of Operating Profit
Other Income/Expense, Net	$99.00K	-$811.0K	$950.0K
YoY Change	-84.08%	-185.37%	-257.02%
Pretax Income	-$6.734M	-$12.12M	-$5.157M
YoY Change	168.82%	134.94%	-16.69%
Income Tax	$583.0K	$567.0K	$580.0K
% Of Pretax Income
Net Earnings	-$7.317M	-$12.68M	-$5.737M
YoY Change	124.17%	121.07%	-11.64%
Net Earnings / Revenue	-10.91%	-20.39%	-11.61%
Basic Earnings Per Share
Diluted Earnings Per Share	-$83.32K	-$146.2K	-$70.03K
COMMON SHARES
Basic Shares Outstanding	29.22M shares
Diluted Shares Outstanding

Balance Sheet

Concept	2018 Q3	2018 Q2	2017 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments	$158.1M	$158.7M	$121.6M
YoY Change	23.13%	30.51%	12.07%
Cash & Equivalents	$67.87M	$73.64M	$53.54M
Short-Term Investments	$90.20M	$85.00M	$68.00M
Other Short-Term Assets	$14.70M	$16.90M	$7.600M
YoY Change	167.27%	122.37%	192.31%
Inventory
Prepaid Expenses
Receivables	$52.94M	$41.39M	$41.31M
Other Receivables	$0.00	$0.00	$0.00
Total Short-Term Assets	$225.7M	$217.0M	$170.5M
YoY Change	26.35%	27.3%	17.91%
LONG-TERM ASSETS
Property, Plant & Equipment	$12.59M	$12.34M	$11.16M
YoY Change	9.39%	10.59%	29.08%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets	$7.601M	$7.724M	$818.0K
YoY Change	782.81%	844.25%	60.08%
Total Long-Term Assets	$20.19M	$20.07M	$11.98M
YoY Change	63.21%	67.52%	30.81%
TOTAL ASSETS
Total Short-Term Assets	$225.7M	$217.0M	$170.5M
Total Long-Term Assets	$20.19M	$20.07M	$11.98M
Total Assets	$245.9M	$237.1M	$182.4M
YoY Change	28.74%	29.94%	18.68%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$3.145M	$1.899M	$1.348M
YoY Change	130.23%	40.88%	-35.0%
Accrued Expenses	$46.10M	$45.50M	$30.80M
YoY Change	43.17%	47.73%	35.68%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$121.8M	$119.1M	$89.57M
YoY Change	32.51%	32.91%	28.44%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$0.00	$0.00
YoY Change
Other Long-Term Liabilities	$7.651M	$7.933M	$5.273M
YoY Change	44.82%	50.45%	-2.23%
Total Long-Term Liabilities	$14.03M	$14.21M	$10.63M
YoY Change	16.54%	33.6%	10.59%
TOTAL LIABILITIES
Total Short-Term Liabilities	$121.8M	$119.1M	$89.57M
Total Long-Term Liabilities	$14.03M	$14.21M	$10.63M
Total Liabilities	$135.8M	$133.3M	$100.2M
YoY Change	30.66%	32.99%	26.27%
SHAREHOLDERS EQUITY
Retained Earnings	-$144.4M	-$137.1M	-$124.7M
YoY Change	12.85%	9.98%	18.42%
Common Stock	$29.00K	$29.00K	$27.00K
YoY Change	3.57%	7.41%	3.85%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$110.1M	$103.8M	$82.23M
YoY Change
Total Liabilities & Shareholders Equity	$245.9M	$237.1M	$182.4M
YoY Change	28.74%	29.94%	18.68%

Cashflow Statement

Concept	2018 Q3	2018 Q2	2017 Q2
OPERATING ACTIVITIES
Net Income	-$7.317M	-$12.68M	-$5.737M
YoY Change	124.17%	121.07%	-11.64%
Depreciation, Depletion And Amortization	$850.0K	$830.0K	$660.0K
YoY Change	23.19%	25.76%	15.79%
Cash From Operating Activities	-$4.110M	$2.940M	-$920.0K
YoY Change	-218.44%	-419.57%	-70.32%
INVESTING ACTIVITIES
Capital Expenditures	-$1.110M	-$990.0K	-$1.030M
YoY Change	6.73%	-3.88%	41.1%
Acquisitions
YoY Change
Other Investing Activities	-$5.150M	-$2.140M	$2.190M
YoY Change	-26.01%	-197.72%	-56.11%
Cash From Investing Activities	-$6.250M	-$3.130M	$1.150M
YoY Change	-21.78%	-372.17%	-73.0%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	4.080M	3.020M	2.260M
YoY Change	-8.52%	33.63%	361.22%
NET CHANGE
Cash From Operating Activities	-4.110M	2.940M	-920.0K
Cash From Investing Activities	-6.250M	-3.130M	1.150M
Cash From Financing Activities	4.080M	3.020M	2.260M
Net Change In Cash	-6.280M	2.830M	2.490M
YoY Change	10366.67%	13.65%	50.91%
FREE CASH FLOW
Cash From Operating Activities	-$4.110M	$2.940M	-$920.0K
Capital Expenditures	-$1.110M	-$990.0K	-$1.030M
Free Cash Flow	-$3.000M	$3.930M	$110.0K
YoY Change	-166.52%	3472.73%	-104.64%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	5273000	USD
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	9663000	USD
	dei	Amendment Flag AmendmentFlag	false
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q1
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2018
	dei	Document Period End Date DocumentPeriodEndDate	2018-06-30
	dei	Document Type DocumentType	10-Q
	dei	Entity Central Index Key EntityCentralIndexKey	0001361113
CY2018Q3	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	29220303	shares
	dei	Entity Filer Category EntityFilerCategory	Large Accelerated Filer
	dei	Entity Incorporation Date Of Incorporation EntityIncorporationDateOfIncorporation	2004-11-24
	dei	Entity Registrant Name EntityRegistrantName	VARONIS SYSTEMS INC
	dei	Trading Symbol TradingSymbol	vrns
CY2017Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	635000	USD
CY2018Q2	us-gaap	Accounts Payable Current AccountsPayableCurrent	1899000	USD
CY2017Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	75596000	USD
CY2018Q2	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	41393000	USD
CY2017Q4	us-gaap	Accrued Liabilities And Other Liabilities AccruedLiabilitiesAndOtherLiabilities	42453000	USD
CY2018Q2	us-gaap	Accrued Liabilities And Other Liabilities AccruedLiabilitiesAndOtherLiabilities	45493000	USD
CY2017Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	136000	USD
CY2018Q2	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-2838000	USD
CY2017Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	223868000	USD
CY2018Q2	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	243733000	USD
CY2017Q2	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	5259000	USD
CY2018Q2	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	8848000	USD
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	15775000	USD
CY2017Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	433000	USD
CY2018Q2	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	395000	USD
	us-gaap	Amortization Of Deferred Sales Commissions AmortizationOfDeferredSalesCommissions	6041000	USD
	us-gaap	Amortization Of Deferred Sales Commissions AmortizationOfDeferredSalesCommissions	6441000	USD
CY2017Q4	us-gaap	Assets Assets	245638000	USD
CY2018Q2	us-gaap	Assets Assets	237067000	USD
CY2017Q4	us-gaap	Assets Current AssetsCurrent	226499000	USD
CY2018Q2	us-gaap	Assets Current AssetsCurrent	217001000	USD
CY2017Q4	us-gaap	Assets Noncurrent AssetsNoncurrent	19139000	USD
CY2018Q2	us-gaap	Assets Noncurrent AssetsNoncurrent	20066000	USD
CY2017Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	53539000	USD
CY2017Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	56689000	USD
CY2018Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	73636000	USD
CY2017Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	54076000	USD
CY2018Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	74156000	USD
CY2016Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	48803000	USD
CY2017Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	54076000	USD
CY2017Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	57236000	USD
CY2018Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	74156000	USD
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	16920000	USD
CY2017Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2018Q2	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2017Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	200000000	shares
CY2018Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	200000000	shares
CY2017Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	28146162	shares
CY2018Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	29218030	shares
CY2017Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	28146162	shares
CY2018Q2	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	29218030	shares
CY2017Q4	us-gaap	Common Stock Value CommonStockValue	28000	USD
CY2018Q2	us-gaap	Common Stock Value CommonStockValue	29000	USD
CY2017Q2	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-5254000	USD
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-14793000	USD
CY2018Q2	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-13548000	USD
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-30703000	USD
	us-gaap	Contract With Customer Liability Revenue Recognized ContractWithCustomerLiabilityRevenueRecognized	48000	USD
CY2017Q2	us-gaap	Cost Of Revenue CostOfRevenue	4881000	USD
	us-gaap	Cost Of Revenue CostOfRevenue	9574000	USD
CY2018Q2	us-gaap	Cost Of Revenue CostOfRevenue	6440000	USD
	us-gaap	Cost Of Revenue CostOfRevenue	12882000	USD
CY2017Q4	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	73493000	USD
CY2018Q2	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	71663000	USD
CY2017Q4	us-gaap	Deferred Revenue Noncurrent DeferredRevenueNoncurrent	6608000	USD
CY2018Q2	us-gaap	Deferred Revenue Noncurrent DeferredRevenueNoncurrent	6274000	USD
	us-gaap	Depreciation Depreciation	1284000	USD
	us-gaap	Depreciation Depreciation	1626000	USD
CY2017Q4	us-gaap	Derivative Fair Value Of Derivative Asset DerivativeFairValueOfDerivativeAsset	163000	USD
CY2018Q2	us-gaap	Derivative Fair Value Of Derivative Liability DerivativeFairValueOfDerivativeLiability	2913000	USD
CY2017Q4	us-gaap	Derivative Liability Notional Amount DerivativeLiabilityNotionalAmount	1746000	USD
CY2018Q2	us-gaap	Derivative Liability Notional Amount DerivativeLiabilityNotionalAmount	35290000	USD
CY2017Q2	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.21
	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.64
CY2018Q2	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.44
	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.97
	us-gaap	Gain Loss On Disposition Of Assets1 GainLossOnDispositionOfAssets1	2000	USD
	us-gaap	Gain Loss On Disposition Of Assets1 GainLossOnDispositionOfAssets1	2000	USD
CY2017Q2	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	6579000	USD
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	12088000	USD
CY2018Q2	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	7989000	USD
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	15058000	USD
CY2017Q2	us-gaap	Gross Profit GrossProfit	44550000	USD
	us-gaap	Gross Profit GrossProfit	79450000	USD
CY2018Q2	us-gaap	Gross Profit GrossProfit	55750000	USD
	us-gaap	Gross Profit GrossProfit	102836000	USD
CY2017Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-5157000	USD
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-16620000	USD
CY2017Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	580000	USD
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	780000	USD
CY2018Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-12116000	USD
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-26635000	USD
CY2018Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	567000	USD
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	1094000	USD
	us-gaap	Income Taxes Paid IncomeTaxesPaid	140000	USD
	us-gaap	Income Taxes Paid IncomeTaxesPaid	486000	USD
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	60000	USD
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	1264000	USD
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-12548000	USD
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-34203000	USD
	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	2769000	USD
	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	217000	USD
	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	838000	USD
	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	-2164000	USD
	us-gaap	Increase Decrease In Other Noncurrent Assets IncreaseDecreaseInOtherNoncurrentAssets	0	USD
	us-gaap	Increase Decrease In Other Noncurrent Assets IncreaseDecreaseInOtherNoncurrentAssets	-16000	USD
	us-gaap	Increase Decrease In Other Noncurrent Liabilities IncreaseDecreaseInOtherNoncurrentLiabilities	-732000	USD
	us-gaap	Increase Decrease In Other Noncurrent Liabilities IncreaseDecreaseInOtherNoncurrentLiabilities	126000	USD
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	1783000	USD
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	3566000	USD
CY2017	us-gaap	Lease And Rental Expense LeaseAndRentalExpense	1814000	USD
	us-gaap	Lease And Rental Expense LeaseAndRentalExpense	2641000	USD
CY2017Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	245638000	USD
CY2018Q2	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	237067000	USD
CY2017Q4	us-gaap	Liabilities Current LiabilitiesCurrent	116581000	USD
CY2018Q2	us-gaap	Liabilities Current LiabilitiesCurrent	119055000	USD
CY2017Q4	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	14415000	USD
CY2018Q2	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	14207000	USD
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	3137000	USD
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	4091000	USD
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-5248000	USD
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-7554000	USD
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	7384000	USD
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	20383000	USD
CY2017Q2	us-gaap	Net Income Loss NetIncomeLoss	-5737000	USD
	us-gaap	Net Income Loss NetIncomeLoss	-17400000	USD
CY2018Q2	us-gaap	Net Income Loss NetIncomeLoss	-12683000	USD
	us-gaap	Net Income Loss NetIncomeLoss	-27729000	USD
CY2017Q4	us-gaap	Noncurrent Assets NoncurrentAssets	11896000	USD
CY2018Q2	us-gaap	Noncurrent Assets NoncurrentAssets	12342000	USD
CY2017Q2	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	950000	USD
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	1419000	USD
CY2018Q2	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-811000	USD
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	167000	USD
	us-gaap	Number Of Reportable Segments NumberOfReportableSegments	1
CY2017Q2	us-gaap	Operating Expenses OperatingExpenses	50657000	USD
	us-gaap	Operating Expenses OperatingExpenses	97489000	USD
CY2018Q2	us-gaap	Operating Expenses OperatingExpenses	67055000	USD
	us-gaap	Operating Expenses OperatingExpenses	129638000	USD
CY2017Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	-6107000	USD
	us-gaap	Operating Income Loss OperatingIncomeLoss	-18039000	USD
CY2018Q2	us-gaap	Operating Leases Future Minimum Payments Due OperatingLeasesFutureMinimumPaymentsDue	88596000	USD
CY2018Q2	us-gaap	Operating Leases Future Minimum Payments Due Future Minimum Sublease Rentals OperatingLeasesFutureMinimumPaymentsDueFutureMinimumSubleaseRentals	333000	USD
CY2018Q2	us-gaap	Operating Leases Future Minimum Payments Due In Five Years OperatingLeasesFutureMinimumPaymentsDueInFiveYears	9443000	USD
CY2018Q2	us-gaap	Operating Leases Future Minimum Payments Due In Four Years OperatingLeasesFutureMinimumPaymentsDueInFourYears	9372000	USD
CY2018Q2	us-gaap	Operating Leases Future Minimum Payments Due In Three Years OperatingLeasesFutureMinimumPaymentsDueInThreeYears	9069000	USD
CY2018Q2	us-gaap	Operating Leases Future Minimum Payments Due In Two Years OperatingLeasesFutureMinimumPaymentsDueInTwoYears	7466000	USD
CY2018Q2	us-gaap	Operating Leases Future Minimum Payments Due Thereafter OperatingLeasesFutureMinimumPaymentsDueThereafter	49547000	USD
CY2018Q2	us-gaap	Operating Leases Future Minimum Payments Remainder Of Fiscal Year OperatingLeasesFutureMinimumPaymentsRemainderOfFiscalYear	3699000	USD
	us-gaap	Operations Commenced Date1 OperationsCommencedDate1	2005-01-01
CY2017Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	7243000	USD
CY2018Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	-11305000	USD
	us-gaap	Operating Income Loss OperatingIncomeLoss	-26802000	USD
CY2018Q2	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	7724000	USD
CY2017Q2	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	483000	USD
	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	2607000	USD
CY2018Q2	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	-865000	USD
	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	-2974000	USD
CY2017Q2	us-gaap	Other Comprehensive Income Unrealized Gain Loss On Derivatives Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax	493000	USD
	us-gaap	Other Comprehensive Income Unrealized Gain Loss On Derivatives Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax	2617000	USD
CY2018Q2	us-gaap	Other Comprehensive Income Unrealized Gain Loss On Derivatives Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax	-884000	USD
	us-gaap	Other Comprehensive Income Unrealized Gain Loss On Derivatives Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax	-2985000	USD
CY2017Q2	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	-10000	USD
	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	-10000	USD
CY2018Q2	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	19000	USD
	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	11000	USD
CY2017Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	7807000	USD
CY2018Q2	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	7933000	USD
	us-gaap	Other Than Temporary Impairment Losses Investments Availableforsale Securities OtherThanTemporaryImpairmentLossesInvestmentsAvailableforsaleSecurities	0	USD
	us-gaap	Payments For Proceeds From Short Term Investments PaymentsForProceedsFromShortTermInvestments	2556000	USD
	us-gaap	Payments For Proceeds From Short Term Investments PaymentsForProceedsFromShortTermInvestments	5166000	USD
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	2534000	USD
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	2072000	USD
CY2017Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	14346000	USD
CY2018Q2	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	16927000	USD
	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment	2000	USD
	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment	2000	USD
	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	3137000	USD
	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	4091000	USD
CY2017Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	11896000	USD
CY2018Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	12342000	USD
CY2017Q2	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	11498000	USD
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	21907000	USD
CY2018Q2	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	17717000	USD
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	33259000	USD
CY2017Q2	us-gaap	Restricted Cash And Cash Equivalents Noncurrent RestrictedCashAndCashEquivalentsNoncurrent	537000	USD
CY2018Q2	us-gaap	Restricted Cash And Cash Equivalents Noncurrent RestrictedCashAndCashEquivalentsNoncurrent	520000	USD
	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	89024000	USD
CY2017Q4	vrns	Financial Assets Liabilities Fair Value Disclosure FinancialAssetsLiabilitiesFairValueDisclosure	86901000	USD
CY2018Q2	vrns	Financial Assets Liabilities Fair Value Disclosure FinancialAssetsLiabilitiesFairValueDisclosure	89233000	USD
	vrns	Increase Decrease In Deferred Commissions IncreaseDecreaseInDeferredCommissions	5902000	USD
	vrns	Increase Decrease In Deferred Commissions IncreaseDecreaseInDeferredCommissions	5824000	USD
CY2018Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-137119000	USD
CY2017Q2	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	49431000	USD
CY2017Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-109390000	USD
CY2018Q2	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1	43205000	USD
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1	P4Y133D
	us-gaap	Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Outstanding Options Weighted Average Remaining Contractual Term2 SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2	P4Y227D
CY2017Q4	us-gaap	Short Term Investments ShortTermInvestments	79868000	USD
CY2018Q2	us-gaap	Short Term Investments ShortTermInvestments	85045000	USD
CY2018Q2	us-gaap	Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Number Of Exercisable Options ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions	765242	shares
CY2018Q2	us-gaap	Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Number Of Outstanding Options ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions	843831	shares
CY2018Q2	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	62190000	USD
	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	115718000	USD
CY2017Q2	us-gaap	Revenues Revenues	49431000	USD
	us-gaap	Revenues Revenues	89024000	USD
CY2018Q2	us-gaap	Revenues Revenues	62190000	USD
	us-gaap	Revenues Revenues	115718000	USD
CY2017Q2	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	32580000	USD
	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	63494000	USD
CY2018Q2	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	41349000	USD
	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	81321000	USD
	us-gaap	Share Based Compensation ShareBasedCompensation	9663000	USD
	us-gaap	Share Based Compensation ShareBasedCompensation	15775000	USD
CY2018Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	765242	shares
CY2018Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	18.041
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue	34458000	USD
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	1234	shares
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	0	shares
CY2017Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	47152000	USD
CY2018Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	47269000	USD
CY2017Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	1456285	shares
CY2018Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	843831	shares
CY2017Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	16.172
CY2018Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	18.483
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	12.97
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice	22.07
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	0
CY2017	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P4Y330D
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P4Y227D
CY2018Q2	us-gaap	Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Exercisable Options Weighted Average Exercise Price1 SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1	18.088
	us-gaap	Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Exercisable Options Weighted Average Remaining Contractual Term2 SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2	P4Y133D
CY2018Q2	us-gaap	Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Outstanding Options Weighted Average Exercise Price Beginning Balance1 SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1	18.483
	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	611220	shares
CY2017Q4	us-gaap	Stockholders Equity StockholdersEquity	114642000	USD
CY2018Q2	us-gaap	Stockholders Equity StockholdersEquity	103805000	USD
CY2017Q2	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	27321837	shares
	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	27137930	shares
CY2018Q2	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	28920314	shares
	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	28643542	shares
CY2016Q1	vrns	Common Stock Capital Shares Reserved For Future Issuance Annual Increase Maximum CommonStockCapitalSharesReservedForFutureIssuanceAnnualIncreaseMaximum	1042766	shares
CY2017Q1	vrns	Common Stock Capital Shares Reserved For Future Issuance Annual Increase Maximum CommonStockCapitalSharesReservedForFutureIssuanceAnnualIncreaseMaximum	1072870	shares
CY2018Q1	vrns	Common Stock Capital Shares Reserved For Future Issuance Annual Increase Maximum CommonStockCapitalSharesReservedForFutureIssuanceAnnualIncreaseMaximum	1125846	shares
	vrns	Increase Decrease In Long Term Deposits IncreaseDecreaseInLongTermDeposits	160000	USD
	vrns	Increase Decrease In Long Term Deposits IncreaseDecreaseInLongTermDeposits	318000	USD
CY2018Q2	vrns	Subsidiary Or Equity Method Investee Number SubsidiaryOrEquityMethodInvesteeNumber	9

Files In Submission

Name	View Source	Status
0001628280-18-009870-index-headers.html	Edgar Link	pending
0001628280-18-009870-index.html	Edgar Link	pending
0001628280-18-009870.txt	Edgar Link	pending
0001628280-18-009870-xbrl.zip	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
vrns-06302018x10q.htm	Edgar Link	pending
vrns-20180630.xml	Edgar Link	completed
vrns-20180630.xsd	Edgar Link	pending
vrns-20180630_cal.xml	Edgar Link	unprocessable
vrns-20180630_def.xml	Edgar Link	unprocessable
vrns-20180630_lab.xml	Edgar Link	unprocessable
vrns-20180630_pre.xml	Edgar Link	unprocessable
vrnsq22018exh311.htm	Edgar Link	pending
vrnsq22018exh312.htm	Edgar Link	pending
vrnsq22018exh321.htm	Edgar Link	pending
vrnsq22018exh322.htm	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$VRNS
VARONIS SYSTEMS INC Stock $vrns

2018 Q3 Form 10-Q Financial Statement

#000162828018009870 Filed on July 31, 2018

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$VRNS VARONIS SYSTEMS INC Stock $vrns

2018 Q3 Form 10-Q Financial Statement

#000162828018009870 Filed on July 31, 2018

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$VRNS
VARONIS SYSTEMS INC Stock $vrns